Qianjun Zhou

About

Qianjun Zhou is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly through robotic-assisted thoracoscopic surgery (RATS). His major contributions center on demonstrating the safety, efficacy, and superior outcomes of robotic segmentectomy and lobectomy compared to traditional video-assisted thoracoscopic surgery (VATS) for early-stage non-small cell lung cancer (NSCLC). In his landmark 2020 study (62 citations), Zhou showed that robotic-assisted segmentectomy offers comparable long-term survival with potentially better operative outcomes for stage IA lung cancer. His 2019 retrospective analysis of 1,075 consecutive p-stage I NSCLC cases (61 citations) remains the largest Chinese series of robotic lobectomy, establishing perioperative advantages over VATS. Zhou has also investigated surgical site infection rates, finding that robotic approaches may reduce this complication. With over 137 combined citations from his most influential works, Zhou has helped position China as a leader in robotic thoracic surgery, providing critical evidence that supports the adoption of RATS as a standard approach for early lung cancer management.

Research Focus

Key Achievements

Top Papers

1. 1
   Operative outcomes and long-term survival of robotic-assisted segmentectomy for stage IA lung cancer compared with video-assisted thoracoscopic segmentectomy

   62 citations · 2020
2. 2
   Perioperative outcomes of radical lobectomies using robotic-assisted thoracoscopic technique vs. video-assisted thoracoscopic technique: retrospective study of 1,075 consecutive p-stage I non-small cell lung cancer cases

   61 citations · 2019
3. 3
   Surgical site infection following minimally invasive lobectomy: Is robotic surgery superior?

   14 citations · 2022

Key Collaborators

Contact & Links